Findings seen in two cohorts of older adults with different sociodemographic characteristics
FRIDAY, May 28, 2021 (HealthDay News) — Tetanus, diphtheria, pertussis (Tdap) vaccination in older adults is associated with a 42 percent lower dementia risk, according to a study recently published in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences.
Jeffrey F. Scherrer, Ph.D., from Saint Louis University, and colleagues assessed whether Tdap vaccination is associated with incident dementia. The analysis included a Veterans Health Affairs (VHA) cohort (96 percent male; 91.2 percent White) and a MarketScan medical claims cohort of older adults (65.4 percent female) free of dementia for two years before the index period (2011 or 2012), with follow-up through 2018.
The researchers found that after controlling for confounding variables, patients with Tdap vaccination had a significantly lower risk for dementia in both cohorts (VHA: hazard ratio, 0.58; MarketScan: hazard ratio, 0.58) compared with older adults without Tdap vaccination.
“Several vaccine types are linked to decreased dementia risk, suggesting that these associations are due to nonspecific effects on inflammation rather than vaccine-induced pathogen-specific protective effects,” the authors write.
One-Hour Cognitive Test Provides Meaningful Information Beyond Traditional Memory Screening
Seniors With Hypertension Benefit From Pausing ACE Inhibitors, ARBs on Morning of Surgery
β3 Agonists Do Not Cut Dementia Risk Versus Anticholinergics in OAB
CDC: 1 in 10 U.S. Adults Reported GLP-1 Medication Use July to August 2025
CTE Pathology Found in Nearly 75 Percent of Deceased Former NFL Players
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers